208 related articles for article (PubMed ID: 24661924)
1. Screening for adrenal suppression in children with inflammatory bowel disease discontinuing glucocorticoid therapy.
Sidoroff M; Kolho KL
BMC Gastroenterol; 2014 Mar; 14():51. PubMed ID: 24661924
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid induced adrenal insufficiency is common in steroid treated glomerular diseases - proposed strategy for screening and management.
Karangizi AHK; Al-Shaghana M; Logan S; Criseno S; Webster R; Boelaert K; Hewins P; Harper L
BMC Nephrol; 2019 May; 20(1):154. PubMed ID: 31060510
[TBL] [Abstract][Full Text] [Related]
3. Evaluating tertiary adrenal insufficiency in rheumatology patients on long-term systemic glucocorticoid treatment.
Sagar R; Mackie S; W Morgan A; Stewart P; Abbas A
Clin Endocrinol (Oxf); 2021 Mar; 94(3):361-370. PubMed ID: 33370485
[TBL] [Abstract][Full Text] [Related]
4. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702
[TBL] [Abstract][Full Text] [Related]
5. High incidence of adrenal suppression in children with Kawasaki disease treated with intravenous immunoglobulin plus prednisolone.
Goto M; Miyagawa N; Kikunaga K; Miura M; Hasegawa Y
Endocr J; 2015; 62(2):145-51. PubMed ID: 25342092
[TBL] [Abstract][Full Text] [Related]
6. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Gordijn MS; Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2015 Aug; (8):CD008727. PubMed ID: 26282194
[TBL] [Abstract][Full Text] [Related]
7. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Gordijn MS; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2012 May; (5):CD008727. PubMed ID: 22592733
[TBL] [Abstract][Full Text] [Related]
8. Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol.
Woods CP; Argese N; Chapman M; Boot C; Webster R; Dabhi V; Grossman AB; Toogood AA; Arlt W; Stewart PM; Crowley RK; Tomlinson JW
Eur J Endocrinol; 2015 Nov; 173(5):633-42. PubMed ID: 26294794
[TBL] [Abstract][Full Text] [Related]
9. Adrenal insufficiency in prednisolone-treated patients with polymyalgia rheumatica or giant cell arteritis-prevalence and clinical approach.
Borresen SW; Thorgrimsen TB; Jensen B; Hilsted L; Bartels EM; Feldt-Rasmussen U; Locht H
Rheumatology (Oxford); 2020 Oct; 59(10):2764-2773. PubMed ID: 32031663
[TBL] [Abstract][Full Text] [Related]
10. Frequency and Duration of Adrenal Suppression Following Glucocorticoid Therapy in Children With Rheumatic Diseases.
Ahmet A; Brienza V; Tran A; Lemieux J; Aglipay M; Barrowman N; Duffy C; Roth J; Jurencak R
Arthritis Care Res (Hoboken); 2017 Aug; 69(8):1224-1230. PubMed ID: 27723273
[TBL] [Abstract][Full Text] [Related]
11. Perioperative glucocorticoid prescribing habits in patients with inflammatory bowel disease: a call for standardization.
Lamore RF; Hechenbleikner EM; Ha C; Salvatori R; Harris LH; Marohn MR; Gearhart SL; Efron JE; Wick EC
JAMA Surg; 2014 May; 149(5):459-66. PubMed ID: 24647868
[TBL] [Abstract][Full Text] [Related]
12. Pituitary-adrenal function after prolonged glucocorticoid therapy for systemic inflammatory disorders: an observational study.
Sacre K; Dehoux M; Chauveheid MP; Chauchard M; Lidove O; Roussel R; Papo T
J Clin Endocrinol Metab; 2013 Aug; 98(8):3199-205. PubMed ID: 23760625
[TBL] [Abstract][Full Text] [Related]
13. CRH test prior to discontinuation of long-term low-dose glucocorticoid therapy.
Gellner R; Stange M; Schiemann U; Domschke W; Hengst K
Exp Clin Endocrinol Diabetes; 1999; 107(8):561-7. PubMed ID: 10612488
[TBL] [Abstract][Full Text] [Related]
14. Impaired adrenal function after glucocorticoid therapy in children with acute lymphoblastic leukemia.
Petersen KB; Müller J; Rasmussen M; Schmiegelow K
Med Pediatr Oncol; 2003 Aug; 41(2):110-4. PubMed ID: 12825213
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the hypothalamic-pituitary-adrenal axis in children with leukemia before and after 6 weeks of high-dose glucocorticoid therapy.
Kuperman H; Damiani D; Chrousos GP; Dichtchekenian V; Manna TD; Filho VO; Setian N
J Clin Endocrinol Metab; 2001 Jul; 86(7):2993-6. PubMed ID: 11443157
[TBL] [Abstract][Full Text] [Related]
16. The low-dose ACTH test does not provide a useful assessment of the hypothalamic-pituitary-adrenal axis in secondary adrenal insufficiency.
Suliman AM; Smith TP; Labib M; Fiad TM; McKenna TJ
Clin Endocrinol (Oxf); 2002 Apr; 56(4):533-9. PubMed ID: 11966747
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic-pituitary-adrenal axis recovery following prolonged prednisolone therapy in infants.
Mendoza-Cruz AC; Wargon O; Adams S; Tran H; Verge CF
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1936-40. PubMed ID: 24081733
[TBL] [Abstract][Full Text] [Related]
18. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.
Abeyagunawardena AS; Hindmarsh P; Trompeter RS
Arch Dis Child; 2007 Jul; 92(7):585-8. PubMed ID: 17284479
[TBL] [Abstract][Full Text] [Related]
19. Prednisolone in the management of patients with Crohn's disease.
Cronin E
Br J Nurs; 2010 Nov 25-Dec 8; 19(21):1333-6. PubMed ID: 21355357
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of hypothalamic-pituitary-adrenal axis recovery after corticotherapy by using basal cortisol secretion].
Silva IN; Cunha CF; Finch FL; Colosimo EA
Arq Bras Endocrinol Metabol; 2006 Feb; 50(1):118-24. PubMed ID: 16628284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
